Irisin: The Exercise Hormone Igniting Metabolic Research

Imagine a single molecule, produced during your workout, that could potentially ripple through your entire body, influencing everything from fat burning to bone strength, and even protecting your brain. That's the exciting prospect researchers are exploring with Irisin, often dubbed the "exercise hormone." This intriguing peptide, released by muscles, has captured scientific attention for its diverse potential roles in health, sparking a flurry of investigations into how it might mediate some of the profound benefits of physical activity (PMID 33493316).

What is Irisin?

Irisin is a secreted peptide derived from a larger membrane-bound protein called fibronectin type III domain-containing 5 (FNDC5) (PMID 36225200). Initially discovered in 2012, it was proposed to be cleaved from skeletal muscle FNDC5 during exercise and travel to white adipose tissue, where it could induce a process known as "browning" (PMID 33493316). This browning converts energy-storing white fat into energy-burning brown-like fat cells (PMID 36225200). While its initial discovery highlighted its metabolic role, subsequent research has unveiled a much broader sphere of influence. Irisin binds to specific receptors, primarily proteins of the αV class of integrins, particularly αV/β5 integrin, to exert its effects (PMID 30550785, PMID 37392517).

Why researchers are excited

The excitement around Irisin stems from its potential to mimic or mediate some of the most profound benefits of physical exercise within the body. Researchers have observed that Irisin levels are significantly lower in conditions like obesity, osteoporosis, muscle atrophy, Alzheimer's disease, and cardiovascular diseases (CVDs) (PMID 36225200). Conversely, it has been found to be higher in patients with certain cancers (PMID 36225200). This association suggests Irisin could be a key player in maintaining overall physiological balance and health. Its ability to influence diverse biological processes, from energy metabolism to bone remodeling and cognitive function, positions it as a highly promising area of study for potential therapeutic strategies (PMID 33493316, PMID 36225200).

What the studies found

Research into Irisin has yielded a range of intriguing findings across various biological models:

| Study | Model | Key finding | PMID | |--------------------------------------------------|-----------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------| | Role of irisin in physiology and pathology | Human patients | Irisin levels are lower in obesity, osteoporosis, muscle atrophy, Alzheimer's disease, and CVDs; higher in cancer. | 36225200 | | Irisin Mediates Effects on Bone and Fat | Osteocytes, fat cells, mice | Irisin binds to αV integrins, increasing osteocytic survival and sclerostin production. Genetic ablation of FNDC5 in mice blocked ovariectomy-induced osteolytic bone loss. | 30550785 | | Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects | AD mouse models | FNDC5/irisin levels were reduced in AD hippocampi and experimental AD models. Boosting brain FNDC5/irisin rescued synaptic plasticity and memory impairments in AD mouse models. Peripheral overexpression of FNDC5/irisin rescued memory impairment. | 30617325 | | Exercise hormone irisin is a critical regulator of cognitive function | Mice (FNDC5 KO, AD models) | Genetic deletion of Fndc5/irisin impaired cognitive function in exercise, aging, and AD mouse models. Delivering irisin into the dentate gyrus or elevating circulating irisin (via liver overexpression) improved cognitive deficits and neuropathology in AD mouse models. | 34417591 | | Irisin inhibits neutrophil extracellular traps formation and protects against acute pancreatitis | Neutrophils (in vitro), mice (AP models) | Irisin significantly reduced neutrophil extracellular traps (NETs) formation in vitro via the P38/MAPK pathway. Systemic irisin treatment reduced tissue damage and NETs formation in two acute pancreatitis (AP) mouse models. | 37392517 | | Irisin attenuates type 1 diabetic cardiomyopathy by anti-ferroptosis | Mice (STZ-induced T1DM) | Irisin expression was lower in the heart and serum of STZ-induced type 1 diabetic cardiomyopathy (T1DM) mice. Irisin supplementation improved impaired cardiac function in these mice by inhibiting ferroptosis, via the SIRT1-p53-SLC7A11/GPX4 pathway. | 38566123 |

How it's thought to work

Irisin exerts its effects by binding to specific receptors. A key breakthrough identified proteins of the αV class of integrins, particularly αV/β5 integrin, as its receptors (PMID 30550785, PMID 37392517). Once bound, Irisin can trigger a cascade of intracellular events. For instance, in bone, it promotes osteoblast proliferation, differentiation, and mineralization through pathways like ERK, p38, and AMPK, while regulating osteoclast differentiation via JNK, Wnt/β-catenin, and RANKL/RANK/OPG signaling (PMID 37669714). In the context of type 1 diabetic cardiomyopathy, Irisin has been shown to improve cardiac function by inhibiting ferroptosis, a type of regulated cell death, through the SIRT1-p53-SLC7A11/GPX4 pathway (PMID 38566123). Furthermore, Irisin can influence inflammation, as seen in its ability to inhibit neutrophil extracellular traps (NETs) formation via the P38/MAPK pathway in vitro (PMID 37392517). In the brain, Irisin's impact on synaptic plasticity and memory in Alzheimer's models suggests a complex neuroprotective mechanism (PMID 30617325).

The catch: what we still don't know

While the research on Irisin is highly promising, it's important to remember that many studies are still in early stages, often involving animal models or cell cultures (PMID 30550785, PMID 30617325, PMID 34417591, PMID 37392517, PMID 38566123). Some initial findings, particularly those correlating plasma Irisin levels with physiological conditions, have faced scrutiny due to concerns about assay accuracy (PMID 33493316). While the receptor for Irisin has been identified as αV integrins, the exact mechanisms for all its reported effects, such as direct regulation of muscle regeneration, promotion of neurogenesis, maintenance of liver glucose homeostasis, or inhibition of cancer development, are not yet fully understood or directly proven (PMID 30550785, PMID 36225200). Questions remain about the role of a mutant start codon in human FNDC5 and the precise mechanism of Irisin's cleavage from its precursor protein (PMID 33493316). Further research, especially using advanced tools like FNDC5 knockout mice, is crucial to resolve existing ambiguities and fully elucidate Irisin's potential (PMID 33493316).

Keep exploring

Irisin represents a captivating frontier in metabolic and physiological research, highlighting the profound connections between physical activity and overall health. As scientists continue to unravel its intricate mechanisms, we may unlock new avenues for addressing complex health challenges. Dive deeper into the world of peptides, compare various compounds, and share this exciting article with fellow enthusiasts interested in the cutting edge of scientific discovery!

Sources

* Role of irisin in physiology and pathology. Frontiers in endocrinology, 2022. https://pubmed.ncbi.nlm.nih.gov/36225200/ * Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. Cell, 2018. https://pubmed.ncbi.nlm.nih.gov/30550785/ * Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models. Nature medicine, 2019. https://pubmed.ncbi.nlm.nih.gov/30617325/ * Progress and Challenges in the Biology of FNDC5 and Irisin. Endocrine reviews, 2021. https://pubmed.ncbi.nlm.nih.gov/33493316/ * Irisin as an agent for protecting against osteoporosis: A review of the current mechanisms and pathways. Journal of advanced research, 2024. https://pubmed.ncbi.nlm.nih.gov/37669714/ * Irisin inhibits neutrophil extracellular traps formation and protects against acute pancreatitis in mice. Redox biology, 2023. https://pubmed.ncbi.nlm.nih.gov/37392517/ * Exercise hormone irisin is a critical regulator of cognitive function. Nature metabolism, 2021. https://pubmed.ncbi.nlm.nih.gov/34417591/ * Irisin attenuates type 1 diabetic cardiomyopathy by anti-ferroptosis via SIRT1-mediated deacetylation of p53. Cardiovascular diabetology, 2024. https://pubmed.ncbi.nlm.nih.gov/38566123/